Follow us on:
Breaking News
September 14, 2026
Breaking News
Breaking News
ThermoFisher_CP_Sterile_Leaderboard_0926
This Week at Contract Pharma
ThermoFisher_Webinar_09-17-26_FeaturedSpotlight

Eli Lilly Completes AtaiBeckley Acquisition

 
Eli Lilly Completes AtaiBeckley Acquisition

Deal adds BPL-003, AtaiBeckley’s lead program for treatment-resistant depression.
Read More >>

Headlines

Breaking News
Promotions & Moves

Takeda R&D President Andy Plump to Retire in 2027

Takeda credits Plump with rebuilding its pipeline and advancing late-stage assets.

SPONSOR

Integrated CRDMO: Quotient Sciences Translational Pharmaceutics®

Integrated development services in the Quotient Sciences Translational Pharmaceutics® platform let you eliminate development bottlenecks caused by vendor complexity. Find out how it works.

Breaking News
Collaborations & Alliances

Servier Becomes Latest Company to License Owkin’s K Pro AI Scientist

AstraZeneca, Boehringer Ingelheim, and Sanofi are some of the other companies that have struck agreements with Owkin.

Breaking News
Promotions & Moves

ShennonBio Names Cyril Konto CEO After $12M Raise

Cyril Konto brings more than 20 years of oncology drug development experience.

SPONSOR

Dear Sponsor, We Regret to Inform You...

Cell based assays keep showing up in FDA Complete Response Letters. Join Solvias experts on Sept 22 for a Contract Pharma webinar on the most common deficiencies and how to strengthen validation.

Pfizer_eBook_0826_BoxAd

Breaking News
Promotions & Moves

SonoThera Appoints Adam Shaywitz Chief Medical Officer

Shaywitz brings two decades of experience in the biopharmaceutical industry, most recently at BridgeBio.

SPONSOR

The New Standard for Complex Biologics Characterization

Discover how MAM and automated glycan analytics are transforming analytical strategy for biopharma teams pursuing BLA submission.

SPONSOR

Stop Risk Before It Starts: Smarter CDMO Strategy

One-size CDMOs fail complex injectables. Discover how tailored fill-finish cuts risk, accelerates timelines, and safeguards your product from vial to patient.

Featured Resources

Solution Center SPOTLIGHT

Lannett CDMO

Lannett CDMO is a US-based contract manufacturing organization with decades of pharmaceutical experience. We specialize in oral solid dose and non-injectable liquid manufacturing, high-potency compounds, and controlled substances. Our comprehensive services include advanced analytics, regulatory support, and supply chain management.

 

Solution Center SPOTLIGHT

Almac Group

Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. We are trusted experts in R&D, diagnostic services, API manufacture, formulation development, clinical trial supply services and technologies through to commercial-scale manufacture and distribution.